Research & Education

Episode 1: EGFR Inhibitors as First-line Therapy in Advanced Non-small Cell Lung Cancer

Dr. Roy Herbst
Dr. Ramaswamy Govindan

Dr. Roy Herbst, professor of thoracic medical oncology at the University of Texas M.D. Anderson Cancer Center and member of the IASLC speaks with Dr. Ramaswamy Govindan, an associate professor of medical oncology at the Washington University School of Medicine in St. Louis about the latest research in using targeted therapies in treating non-small cell lung cancer.